+ Site Statistics
References:
54,258,434
Abstracts:
29,560,870
PMIDs:
28,072,757
+ Search Articles
+ Subscribe to Site Feeds
Most Shared
PDF Full Text
+ PDF Full Text
Request PDF Full Text
+ Follow Us
Follow on Facebook
Follow on Twitter
Follow on LinkedIn
+ Translate
+ Recently Requested

Disease duration as an indicator of the efficacy of liraglutide in patients with type 2 diabetes mellitus



Disease duration as an indicator of the efficacy of liraglutide in patients with type 2 diabetes mellitus



Journal of Diabetes Investigation 9(4): 979-980



Comment on the article of Usui et al. Retrospective cohort study of obese patients with type 2 diabetes mellitus (n = 69) demonstrates that the glucose-lowering effect of liraglutide as add on therapy to insulin relies on the remaining beta-cell function in type 2 diabetes. Shorter disease duration implies a more favourable prognosis for response on instantaneous substitution of insulin with liraglutide (HR 2.39 (95% CI: 1.20-4.76).

(PDF emailed within 0-6 h: $19.90)

Accession: 058427262

Download citation: RISBibTeXText

PMID: 29974671

DOI: 10.1111/jdi.12857


Related references

Liraglutide effect and action in diabetes-In (LEAD-In): A prospective observational study assessing safety and effectiveness of liraglutide in patients with type 2 diabetes mellitus treated under routine clinical practice conditions in India. Indian Journal of Endocrinology and Metabolism 20(6): 838-845, 2016

Durable efficacy of liraglutide in patients with type 2 diabetes and pronounced insulin-associated weight gain: 52-week results from the Effect of Liraglutide on insulin-associated wEight GAiN in patients with Type 2 diabetes' (ELEGANT) randomized controlled trial. Journal of Internal Medicine 279(3): 283-292, 2016

The Effectiveness of Liraglutide in Nonalcoholic Fatty Liver Disease Patients with Type 2 Diabetes Mellitus Compared to Sitagliptin and Pioglitazone. The Scientific World Journal 2012: 1-8, 2012

Effect of Liraglutide on Cardiovascular Events in Patients With Type 2 Diabetes Mellitus and Polyvascular Disease: Results of the LEADER Trial. Circulation 137(20): 2179-2183, 2018

The effectiveness of liraglutide in nonalcoholic fatty liver disease patients with type 2 diabetes mellitus compared to sitagliptin and pioglitazone. Thescientificworldjournal 2012: 496453-496453, 2013

Diabetes duration and the efficacy and safety of insulin glargine versus comparator treatment in patients with type 2 diabetes mellitus. Endocrine Practice 20(2): 120-128, 2016

Efficacy and safety comparison of liraglutide, glimepiride, and placebo, all in combination with metformin, in type 2 diabetes: the LEAD (liraglutide effect and action in diabetes)-2 study. Diabetes Care 32(1): 84-90, 2008

Serum leptin level as an indicator to predict the clinical efficacy of troglitazone in patients with type 2 diabetes mellitus. Diabetes Research & Clinical Practice 53(3): 161-164, September, 2001

Association of periodontal disease severity with diabetes duration and diabetic complications in patients with type 1 diabetes mellitus. Journal of the International Academy of Periodontology 8(4): 109-114, 2006

Liraglutide: a review of its use in adult patients with type 2 diabetes mellitus. Drugs 74(18): 2161-2174, 2015

A review of efficacy and safety data regarding the use of liraglutide, a once-daily human glucagon-like peptide 1 analogue, in the treatment of type 2 diabetes mellitus. Clinical Therapeutics 31(11): 2472-2488, 2010

Ecg changes in patients with type i diabetes mellitus depending on the duration of the disease. Problemy Endokria 37(5): 13-16, 1991

ECG changes in patients with type I diabetes mellitus as a function of disease duration. Problemy Endokrinologii 37(5): 13-16, 1991

Efficacy, safety, and tolerability of exenatide once weekly in patients with type 2 diabetes mellitus: an integrated analysis of the DURATION trials. Postgraduate Medicine 125(3): 47-57, 2013

Alternative dosing strategies for liraglutide in patients with type 2 diabetes mellitus. American Journal of Health-System Pharmacy 71(3): 223-226, 2014